United States · Manufacturing startup
United States · Sydnexis
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Funding reportedLast round: Series B
What company datasets say Sydnexis raised
Funding, as reported
Reported in all$50Min dollars
Rounds2
Last roundSeries B
Last round dateAug 2021
Investors listed6
SEC Form D$72M sold, 4 filings, last Apr 2025
Founders and team
From Sydnexis's own website: 5 on the team.
- Perry J. SternbergChief Executive Officer
- Paul ChuVice President, Finance and Business Development
- Nick RuthChief Commercial Officer
- Jeffry WeinhuffChairman of the Board of Sydnexis
- Laura ScottExecutive Business Partner to Perry Sternberg
On 3 portfolio pages
Investors who name them
Each firm lists Sydnexis on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Manufacturing in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Sydnexis in front of investors. Or tell us what we have wrong.